Fulcrum Therapeutics (FULC) Capital Leases (2018 - 2021)

Fulcrum Therapeutics (FULC) has 4 years of Capital Leases data on file, last reported at $2.6 million in Q4 2021.

• Capital Leases for Q4 2021 came in at $2.6 million, down 15.37% year-over-year; the trailing twelve-month figure through Dec 2021 was $2.6 million (down 15.37% YoY), and the FY2021 annual result was $2.6 million, down 15.37% from the prior year.
• Capital Leases fell to $2.6 million in Q4 2021 per FULC's latest filing, from $2.7 million in the prior quarter.
• Over five years, Capital Leases peaked at $4.0 million in Q4 2018 and troughed at $2.6 million in Q4 2021.
• A 4-year average of $3.2 million and a median of $3.2 million in 2020 frame the typical range for Capital Leases.
• The sharpest annual moves came in 2019 and 2021: Capital Leases declined 11.75% in 2019, then decreased 15.37% in 2021.
• A 4-year view of Capital Leases shows it stood at $4.0 million in 2018, then slipped by 11.75% to $3.5 million in 2019, then retreated by 13.35% to $3.1 million in 2020, then declined by 15.37% to $2.6 million in 2021.
• Business Quant data shows FULC's Capital Leases at $2.6 million in Q4 2021, $2.7 million in Q3 2021, and $2.8 million in Q2 2021.